Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

21

Revenue 2017

Biogen Idec

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Biogen Idec's 2013 Oncology and CNS sales performance.

Biogen Idec Inc.

New report identifies key issues with NICE’s methods for evaluating Alzheimer’s drugs

New report identifies key issues with NICE’s methods for evaluating Alzheimer’s drugs

While there are currently no licensed DMDTs in the UK, several are at varying stages of development and regulatory approval, including Eisai and Biogen’s lecanemab and Eli Lilly’s donanemab.

Alzheimer’s Research UK survey highlights dementia knowledge gaps

Alzheimer’s Research UK survey highlights dementia knowledge gaps better.”. Last month, new data showed that a weekly subcutaneous dose of Biogen and Eisai’s Alzheimer’s disease drug Leqembi (lecanemab-irmb) removed 14% more amyloid plaque than the

Biogen/Eisai’s Alzheimer’s disease drug shows promise as subcutaneous formulation

Biogen/Eisai’s Alzheimer’s disease drug shows promise as subcutaneous formulation Biogen and Eisai’s Alzheimer’s disease drug has shown promise as a subcutaneous (SC) formulation, according to new data presented by Eisai at this year’s Clinical Trials on

Biogen’s Actemra biosimilar approved by FDA to treat adult and paediatric arthritis

Biogen’s Actemra biosimilar approved by FDA to treat adult and paediatric arthritis Biogen and Bio-Thera signed a global commercialisation agreement for Tofidence in 2021. ... In a statement, Biogen said it is “currently evaluating the potential launch timeline for Tofidence in the US”.

Innovate UK awards Sano Genetics £330,000 grant for ALS study

Innovate UK awards Sano Genetics £330,000 grant for ALS study Participants will also have the opportunity to take part in new research studies as well as potentially take part in the testing of new therapies, including Biogen’s Qalsody (tofersen), the

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Subscribe to our email news alerts

PMHub

Add my company
Health Unlimited

Health Unlimited is a global health consultancy and communications agency built by specialists with unmatched experience, perspective and expertise. For...

Latest intelligence

Clinical Trials Investigator and Patient Engagement Planning: A Customer Story
...
New Playbook Alert: Virtual Patient Engagement
...
Millennials: the wellness generation
Looking at the results from a global healthcare research study focusing on the patients of the future...